UBS maintains a 'Buy' on Medco Health Solutions (NYSE: MHS), PT increased from $70 to $76.

UBS analyst says, "The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE